Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel, small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases.
March 2020
2020 Annual Meeting of Stockholders
Receive updates straight into your inbox
Rigel Pharmaceuticals, Inc.
1180 Veterans Blvd
South San Francisco, CA 94080
Rigel Pharmaceuticals, Inc.
David Burke
Director, Investor Relations & Communications
ir@rigel.com
EQ Shareowner Services
T: 800-401-1957